Rectal absorption of nitrofurantoin.
The adsorption in humans of nitrofurantoin from seven suppository bases was studied using urinary excretion measurements. Rectal absorption was poorer than GI absorption. The administration of 400 mg of nitrofurantoin in a polyethylene glycol-polysorbate 80 suppository base and in a polyethylene glycol-silica suppository based provided an adequate urinary concentration of nitrofurantoin. Persons who cannot tolerate orally administered nitrofurantoin due to gastric upset could receive nitrofurantoin therapy rectally.
D000284:Administration, Oral; D000328:Adult; D005079:Excipients; D006801:Humans; D007408:Intestinal Absorption; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D009582:Nitrofurantoin / Q000008:administration & dosage / Q000378:metabolism* / Q000652:urine; D012007:Rectum / Q000378:metabolism*; D012995:Solubility; D013488:Suppositories
D005079:Excipients; D013488:Suppositories; D009582:Nitrofurantoin